As we close out this year, we're happy to report it's been an unusually productive one, and historic in many ways. We strongly believe that we're entering a century of TechBio, where biology shifts from a stochastic act of discovery to one that looks much more like Tech and its engineering perspective, driven by an iterative and linear process. In fact, TechBio today feels a lot like where digital and the information age was 40-50 years ago, poised to touch all of our lives.

We are incredibly fortunate to have assembled a strong network and set of portfolio companies within TechBio℠, and believe this convergence within which we operate will continue to play out over the next century.

Here's to another year of finding disease cures, increasing access to care, and improving quality of life for all individuals. Wishing you a happy new year, and we hope to see you in-person in 2022!

View our 2021 Year in Review here:

www.av.co/2021